Net profit of Ipca Laboratories rose 21.31% to Rs 233.21 crore in the quarter ended June 2025 as against Rs 192.24 crore during the previous quarter ended June 2024. Sales rose 10.33% to Rs 2308.85 crore in the quarter ended June 2025 as against Rs 2092.63 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 2308.85 | 2092.63 | 10 |
| OPM % | 18.04 | 18.77 | - |
| PBDT | 430.57 | 389.28 | 11 |
| PBT | 330.51 | 290.39 | 14 |
| NP | 233.21 | 192.24 | 21 |